Literature DB >> 640582

Effect of somatostatin on exocrine pancreatic secretion stimulated by pancreozymin-secretin or by a test meal in the dog.

L Kayasseh, K Gyr, G A Stalder, W W Rittmann, J Girard.   

Abstract

In 4 dogs with chronic duodenal and gastric fistulae, exocrine pancreatic function was assessed by cannulating the pancreatic duct and collecting the duodenal contents. Both methods were applied in each animal. Pancreatic secretion was stimulated by infusion of 2 CHR units of pancreozymin and secretin or by administration of a liquid test meal, injected into the stomach through the gastric fistula. During both experiments 3.5 microgram/kg somatostatin was given as bolus injection followed by an infusion of 3.5 microgram/kg/h. Somatostatin caused a significant reduction in protein and amylase output and in the bicarbonate concentration during stimulation with pancreozymin-secretin. Volume and bicarbonate slightly decreased but not to a significant extent. Duodenal volume and the duodenal activities of trypsin and amylase were significantly reduced during test meal stimulation and somatostatin infusion. Somatostatin is a potent inhibitor of exocrine pancreatic function mainly influencing enzyme secretion.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 640582     DOI: 10.1159/000178911

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  3 in total

1.  Potentiation of cholecystokinin-induced exocrine secretion by both exogenous and endogenous insulin in isolated and perfused rat pancreata.

Authors:  A Saito; J A Williams; T Kanno
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

2.  Immunological blocking of exogenous and endogenous secretin in the dog.

Authors:  L Kayasseh; K Gyr; J B Baumann; J Girard
Journal:  Experientia       Date:  1979-12-15

3.  Effect of two new antisecretory drugs on fluid and electrolyte transport in a patient with secretory diarrhoea.

Authors:  C Edwards; P A Cann; N W Read; C D Holdsworth
Journal:  Gut       Date:  1986-05       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.